RESEARCH
ALK Fusions Identified as Rare but Targetable Drivers in Colorectal CancerComprehensive genomic profiling of 56,206 advanced colorectal tumors characterized the prevalence and therapeutic implications of ALK fusions, which are established targets in lung cancer but rare in CRC. (The Oncologist)